Cypress Capital Management LLC (Wy) Abb Vie Inc. Transaction History

Cypress Capital Management LLC (Wy)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $21,280 - $24,156	-200 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $32,250 - $48,895	-500 Reduced 71.43%	200 $15,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $36,402 - $43,766	-578 Reduced 45.23%	700 $53,000
Q3 2018 Oct 31, 2018	BUY	$88.91 - $98.84 $35,564 - $39,536	400 Added 45.56%	1,278 $121,000
Q1 2018 May 03, 2018	BUY	$92.01 - $123.21 $20,978 - $28,091	228 Added 35.08%	878 $83,000
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $58,214 - $63,836	-650 Reduced 50.0%	650 $63,000
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $90,804 - $115,986	1,300	1,300 $116,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.